EUVIMEDEUVIMED entdecken
Fallbericht

Esketamine for treatment of depression in Huntington's disease: A case report

Carsten Saft, Julia Jessen iD, David Kiefner iD, Georg Juckel

Journal of Huntington's Disease · 2026-11 · 15 (4) · 663-665

DOI: 10.1177/18796397261489245 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Huntington's Disease, online erschienen am 17.09.2026. Verfasst von Carsten Saft und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Huntington-Centre NRW, St Josef Hospital, Ruhr-University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Huntington Disease, Antidepressive Agents, Ketamine, Depression. Die Arbeit nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression and suicidal ideation are common in Huntington's disease (HD). We report a 60-year-old male with HD who suffered from treatment-resistant depression with intermittent suicidal thoughts for 20 years, irritability and apathy. Despite multiple trials of antidepressants, no sustained improvement was achieved. Under nasal esketamine treatment his mood improved dramatically after three treatment days. Beck Depression Inventory (BDI) score dropped from 29 to 5. In a three-month follow-up investigation depression worsened again (BDI score: 20). To our knowledge, this is the first reported case of esketamine use in HD, suggesting that esketamine may be a treatment option for psychiatric symptoms in HD, particularly treatment-resistant depression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Huntington DiseaseAntidepressive AgentsKetamineDepressionDepressive Disorder, Treatment-ResistantHumansMaleMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

Huntington's diseaseantidepressive treatmentdepressionesketaminepsychiatric symptoms

Substanzen

Antidepressive AgentsKetamineEsketamine

Autor:innen und Institutionen

  • Department of Neurology, Huntington-Centre NRW, St Josef Hospital, Ruhr-University Bochum, Bochum, Germany.
  • Department of Psychiatry, Psychotherapy and Preventive Medicine, LWL University Hospital, Ruhr University Bochum, Bochum, Germany.

ORCID-Profile: Julia Jessen, David Kiefner

Zitieren

APA

Saft, C., Jessen, J., Kiefner, D., & Juckel, G. (2026). Esketamine for treatment of depression in Huntington's disease: A case report. Journal of Huntington's Disease, 15(4), 663-665. https://doi.org/10.1177/18796397261489245

Vancouver

Saft C, Jessen J, Kiefner D, Juckel G. Esketamine for treatment of depression in Huntington's disease: A case report. Journal of Huntington's Disease. 2026;15(4):663-665. doi:10.1177/18796397261489245

BibTeX
@article{Saft2026,
  author = {Saft, Carsten and Jessen, Julia and Kiefner, David and Juckel, Georg},
  title = {Esketamine for treatment of depression in Huntington's disease: A case report},
  journal = {Journal of Huntington's Disease},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {663--665},
  doi = {10.1177/18796397261489245}
}
Kostenlos starten →